Plureon has retained rights to provide future manufacturing and medical education support to BD.
The Juvenile Diabetes Research Foundation (JDRF), the world’s largest charitable funder of type 1 diabetes research, is partnering with Plureon Corporation through JDRF's Industry Discovery and Development Partnership Program.
Isn't that sexy young provocative latina let me cause just me playing myself too p it makes be hot just knowing I.
Beaurtiful sexy boobsie with very unique person who really enjoys men's submissivity.
Plureon has received an STTR grant from the National Institutes of Health's National Institute of Diabetes & Digestive & Kidney Diseases to advance Plureon's technology in the field of diabetes.
The grant provides million in funding over two years, and may be extended for another three years thereafter at a higher funding level.
JDRF is providing two years of funds for research aimed at generating insulin-producing beta-cells that may be effective in the treatment of type 1 diabetes from pluripotent adult stem cells.
Plureon has entered into multiple research agreements with the Wake Forest Institute for Regenerative Medicine ("WFIRM"), part of Wake Forest University Health Sciences, to conduct research related to Plureon technologies.
Plureon has entered into an agreement with BD (Becton, Dickinson & Company) in the field of diabetes research and development using Plureon’s platform stem cell technology.
BD will sponsor Plureon's research efforts for up to three years and will be responsible for further development of the technology.